Calm vs Regeneron Pharmaceuticals
Side-by-side comparison of AI visibility scores, market position, and capabilities
Calm is a leading mental wellness app offering sleep, meditation, and relaxation content with enterprise health benefits programs serving over 100 million downloads.
About
Calm is a digital mental health company founded in 2012 by Michael Acton Smith and Alex Tew that has grown into one of the most downloaded and highest-grossing health apps globally. The platform offers guided meditations, sleep stories narrated by celebrities, breathing exercises, and relaxing music designed to reduce stress, improve sleep quality, and support overall mental wellness. Calm has exceeded 100 million downloads and reached a $2B valuation with backing from TPG, making it one of the most valuable standalone consumer wellness applications. The company has expanded into enterprise with Calm Business, providing employee mental health and wellbeing benefits to thousands of organizations. Calm has invested heavily in content production, partnering with prominent voices including LeBron James, Matthew McConaughey, and Harry Styles for exclusive audio content. The company also offers Calm Kids with age-appropriate mindfulness content for children. While positioned primarily as a consumer wellness tool rather than a clinical platform, Calm's scale and brand recognition have made it a leading solution for companies seeking accessible, low-friction mental wellness benefits for large employee populations.
Regeneron (REGN) reported $13.9B revenue in FY2024, up 7% YoY. Top biotech company. Dupixent franchise >$14B. Leaders in eye disease, immunology, oncology. HQ: Tarrytown, NY.
About
Regeneron Pharmaceuticals, Inc. is a leading biotechnology company specializing in the discovery, development, and commercialization of medicines for serious diseases, headquartered in Tarrytown, New York. Founded in 1988 by Leonard Schleifer and George Yancopoulos, Regeneron developed its own proprietary drug discovery technology platform (VelociGene, VelocImmune) that has enabled the development of multiple breakthrough medicines. The company reported revenues of $13.9B in FY2024, up 7% year-over-year.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.